homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

February 1, 2002

Xcyte Therapies

Xcyte Therapies has appointment Scott Minick to chairman. Minick has served as a consultant to Xcyte Therapies for the past two years. He was previously a venture partner with Arch Venture Partners and the president and chief operating officer of Sequus Pharmaceuticals. Seattle-based Xcyte is developing therapies that harness the power of the immune system to treat cancer and other serious illnesses.




Email or user name:
Password:
 
Forgot password? Click here.